Volastra Therapeutics In-Licenses Clinical Stage KIF18A Inhibitor and Secures $60 Million in Series A Funding to Further Advance Cancer-Focused Pipeline

Post by: Meyer in Health Care Press Releases
Ocean Road Advisors has been a long-time investor in Volastra Therapeutics, providing seed financing to the company in 2017 during…
read more
08 Mar 2023
0